Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Epidemiology: A mortal foe

Tuberculosis is one of the world's most lethal infectious diseases. Further progress in consigning it to the past is a massive challenge. By Tom Paulson.

Global burden of tuberculosis

In 2011, nearly 9 million people fell ill from TB and 1.4 million died, mostly in poor countries, with 60% of cases in Asia and 24% in Africa (Fig. 1).

Figure 1
figure1

WORLD TUBERCULOSIS REPORT 2012

The biggest killer

Tuberculosis has killed more than any other infectious disease in history. Over a billion lives in the past two hundred years (Fig. 2).

Figure 2
figure2

WORLD TUBERCULOSIS REPORT 2012

The 100 years battle

Rising living standards in industrialized nations, interrupted by two World wars, and new antibiotics had tuberculosis in decline (Fig. 3).

Figure 3
figure3

LIENHARDT, C. ET AL. NATURE REVIEWS MICROBIOLOGY 10, 407-416 (2012)

Slow progress

Over the past fifteen years, an invigorated anti-TB effort has begun to reduce the global burden of disease worsened by HIV (Fig. 4).

Figure 4
figure4

WORLD TUBERCULOSIS REPORT 2012

传播周期

Fig. 5

figure5

Figure 5

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Paulson, T. Epidemiology: A mortal foe.Nature502,S2–S3 (2013). https://doi.org/10.1038/502S2a

Download citation

Further reading

Comments

By submitting a comment you agree to abide by ourTermsandCommunity Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for theNature Briefingnewsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing